Nanotechnology

A global leader in nanotechnology risk assessment and research, Intertox helps companies across industries navigate risk assessment analysis and regulation for the emerging and ever-evolving field of nanotechnology. With companies adopting more nanotechnologies, we analyze how clients use engineered nanomaterials and develop cost-effective systems to then evaluate impact on workers, customers and the environment.

Clients rely on our science-based expertise of engineered nanomaterials to help draft, revise and set corporate standards and policies around nanotechnology that reduce toxicological risk and establish clear safety protocols to address regulatory concerns.

Our work in nanotechnology remains at the forefront of the field due to our CEO Dr. Richard Pleus’ leadership in the environmental health and safety community’s research efforts to improve nanotechnology risk assessment. He currently leads the U.S. ISO/TC 229 Working Group 3 to set physical and chemical parameters of engineered nano-objects relevant for toxicological assessment and also works to translate insights into efficient ways of predicting nanomaterial risk, such as in silico testing techniques. As co-author of the science textbook Physicochemical Properties of Nanomaterials, Dr. Pleus’ knowledge contributes to the nanomaterials education for toxicologists and risk managers of the future.

• Establishing parameters for toxicological assessments of nanomaterials.
• Developing cost-effective techniques and models to predict chemical and exposure risk of nanomaterials.
• Developing and revising corporate policies and standards on chemical risk of engineered nanomaterials.

• Designed an in silico model for a global insurance company to predict nano-risk during product appraisals for insurance applications.
• Evaluated workers’ risk of exposure to airborne nanoparticles while sanding and grinding composite materials containing carbon nanotubules.